Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.
- DOI
- 10.2967/jnumed.126.272258
- Published
- 2026 Sep 2
- Container
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2967/jnumed.126.272258,
title = {Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.},
author = {Krebs S and Salem AE and Nguyen NC and Sheth RA and Karam JA and Daw NC and Tang C and Tannir NM and Msaouel P and Surasi DS},
year = {2026},
journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
doi = {10.2967/jnumed.126.272258},
url = {https://doi.org/10.2967/jnumed.126.272258}
}RIS
TY - JOUR TI - Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management. AU - Krebs S AU - Salem AE AU - Nguyen NC AU - Sheth RA AU - Karam JA AU - Daw NC AU - Tang C AU - Tannir NM AU - Msaouel P AU - Surasi DS PY - 2026 JO - Journal of nuclear medicine : official publication, Society of Nuclear Medicine DO - 10.2967/jnumed.126.272258 UR - https://doi.org/10.2967/jnumed.126.272258 ER -
APA
S, K., AE, S., NC, N., RA, S., JA, K., NC, D., C, T., NM, T., P, M., & DS, S. (2026). Renal Medullary Carcinoma: Utility of [(18)F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. https://doi.org/10.2967/jnumed.126.272258
Source records
- pubmed · retrieved 2026-09-27T16:47:11.529Z